Skip to content
AwardedSpainGoods

Koduse peritoneaaldialüüsi lahused ja tarvikud

Published
Published 13 October 2025
Deadline
Closed 12 November 2025

Overview

Käesoleva hanke eesmärk on kodust peritoneaaldialüüsi vajavate haigete jaoks peritoneaaldialüüsi teenuse ost vastavalt nefroloogi otsusele, lähtuvalt põhi- ja kaasnevatest haigustest ning haige vajadustest ja võimalustest. Teenus sisaldab koduseks peritoneaaldialüüsiks vajalikke süsteeme, seadmeid, vajadusel nende asendamist ning peritoneaaldialüüsiks igale patsiendile vajaminevaid lahuseid ja lisatarvikuid ning nende transporti haigeni. Lepingu objektiks on Pakkuja poolt Hankijale peritoneaaldialüüsi vajavate haigete jaoks peritoneaaldialüüsi süsteemi kasutada andmine koos hooldusega ning peritoneaaldialüüsiks igale Hankija patsiendile vajaminevate lahuste ja lisatarvikute müümine ning toodete koolitust arstidele ja õdedele. / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Open
Published
13 October 2025
Deadline
Closed
Classification (CPV)
Haemodialysis devices

Award outcome

Awarded value
€1,102,974
Award date
25 November 2025
Contract period
15 December 2025 → 24 November 2029
Winner
  • OÜ Medpharma

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    27 November 2025

  2. Contract Notice

    13 October 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Koduse peritoneaaldialüüsi lahused ja tarvikud — won by OÜ Medpharma — Skim